Cargando…
Exploring the potential of eRNAs in cancer immunotherapy
Autores principales: | Luo, Lianxiang, Chen, Xinming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647423/ https://www.ncbi.nlm.nih.gov/pubmed/36381659 http://dx.doi.org/10.1016/j.omto.2022.10.009 |
Ejemplares similares
-
Enhancer RNAs (eRNAs) in Cancer: The Jacks of All Trades
por: Napoli, Sara, et al.
Publicado: (2022) -
eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer
por: Zhang, Xiaona, et al.
Publicado: (2020) -
Potential mechanisms and prognostic model of eRNAs-regulated genes in stomach adenocarcinoma
por: Gao, Liuying, et al.
Publicado: (2022) -
Enhancer RNAs (eRNAs): New Insights into Gene Transcription and Disease Treatment
por: Ding, Mengting, et al.
Publicado: (2018) -
Identification of prognostic and immunotherapy-related eRNA ID2-AS1 in bladder cancer
por: Zhang, Lei, et al.
Publicado: (2022)